Sign in

CIK 0001104506 · Large accelerated filer

Ticker
INSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
VA
Entity type
operating
EIN
541972729
Phone
908-977-9900
Business address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,737,650
in 2 filings

Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brennan David R −$3.1M Director sold 39% of stake
  2. SHAROKY MELVIN MD −$638K Director sold 100% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-05 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −869 $152.44 $132K 83,243
2026-02-03 Smith Michael Alexander Chief Legal Officer Sale −640 $156.27 $100K 56,397
2026-02-03 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −795 $155.77 $124K 84,112
2026-02-03 Adsett Roger Chief Operating Officer Sale −791 $156.17 $124K 106,810
2026-02-03 Bonstein Sara Chief Financial Officer Sale −748 $156.34 $117K 79,758
2026-02-03 Lewis William Chair and CEO Sale −3,009 $156.34 $470K 303,882
2026-02-02 Flammer Martina M.D. Chief Medical Officer Option exercise 10b5-1 +7,982 $65.72 $525K 92,889
2026-02-02 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −563 $152.06 $86K 92,326
2026-02-02 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −928 $153.16 $142K 91,398
2026-02-02 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −3,349 $154.56 $518K 88,049
2026-02-02 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −3,042 $155.46 $473K 85,007
2026-02-02 Flammer Martina M.D. Chief Medical Officer Sale 10b5-1 −100 $156.86 $16K 84,907
2026-02-02 Flammer Martina M.D. Chief Medical Officer Option exercise · Stock Option (right to buy) 10b5-1 −7,982 23,948
2026-01-20 Lewis William Chair and CEO Option exercise 10b5-1 +6,259 $30.46 $191K 313,150
2026-01-20 Lewis William Chair and CEO Option exercise 10b5-1 +4,440 $17.16 $76K 317,590
2026-01-20 Lewis William Chair and CEO Sale 10b5-1 −1,006 $156.80 $158K 316,584
2026-01-20 Lewis William Chair and CEO Sale 10b5-1 −1,243 $158.37 $197K 315,341
2026-01-20 Lewis William Chair and CEO Sale 10b5-1 −5,967 $158.99 $949K 309,374
2026-01-20 Lewis William Chair and CEO Sale 10b5-1 −2,229 $159.85 $356K 307,145
2026-01-20 Lewis William Chair and CEO Sale 10b5-1 −254 $160.70 $41K 306,891

Page 9 of 23 · 448 trades